tiprankstipranks
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market

Entrada Therapeutics Inc (TRDA) Income Statement

Compare
86 Followers

Entrada Therapeutics Inc Income Statement

Last quarter (Q3 2024), Entrada Therapeutics Inc's total revenue was $19.57M, a decrease of -55.25% from the same quarter last year. In Q3, Entrada Therapeutics Inc's net income was $-14.03M. See Entrada Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 129.01M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 29.13M$ -1.90M$ -1.12M$ -326.00K$ -104.00K
Operating Expenses
$ 132.18M$ 97.25M$ 51.13M$ 26.67M$ 11.82M
Depreciation and Amortization
$ 2.84M$ 1.90M$ 1.12M$ 326.00K$ 104.00K
EBITDA
$ -321.00K$ -95.35M$ -50.01M$ -26.34M$ -11.72M
Operating Income
$ -3.16M$ -97.25M$ -51.13M$ -26.67M$ -11.82M
Other Income/Expenses
$ 15.22M$ 2.63M$ -31.00K$ 144.00K$ 6.72M
Pretax Income
$ 12.06M$ -94.62M$ -51.16M$ -26.52M$ -5.10M
Net Income
$ -6.68M$ -87.46M$ -50.07M$ -26.38M$ -4.65M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.20$ -2.79$ -1.60$ -0.84$ -0.15
Diluted EPS
$ -0.20$ -2.79$ -1.60$ -0.84$ -0.15
Weighted Average Shares Outstanding
33.05M 31.29M 31.22M 31.25M 31.25M
Weighted Average Shares Outstanding (Diluted)
33.05M 31.29M 31.22M 31.25M 31.25M
Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis